- Home
- CMPX vs FBLG Comparison
CMPX vs FBLG Comparison
Compare CMPX & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- FBLG
- Stock Information
- Founded
- CMPX 2014
- FBLG 2021
- Country
- CMPX United States
- FBLG United States
- Employees
- CMPX N/A
- FBLG N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- CMPX Health Care
- FBLG
- Exchange
- CMPX Nasdaq
- FBLG NYSE
- Market Cap
- CMPX 217.4M
- FBLG 163.3M
- IPO Year
- CMPX N/A
- FBLG 2024
- Fundamental
- Price
- CMPX $1.63
- FBLG $3.24
- Analyst Decision
- CMPX Strong Buy
- FBLG Strong Buy
- Analyst Count
- CMPX 3
- FBLG 1
- Target Price
- CMPX $7.67
- FBLG $16.00
- AVG Volume (30 Days)
- CMPX 410.9K
- FBLG 791.5K
- Earning Date
- CMPX 11-07-2024
- FBLG 11-02-2024
- Dividend Yield
- CMPX N/A
- FBLG N/A
- EPS Growth
- CMPX N/A
- FBLG N/A
- EPS
- CMPX N/A
- FBLG N/A
- Revenue
- CMPX $850,000.00
- FBLG N/A
- Revenue This Year
- CMPX N/A
- FBLG N/A
- Revenue Next Year
- CMPX $950.68
- FBLG N/A
- P/E Ratio
- CMPX N/A
- FBLG N/A
- Revenue Growth
- CMPX N/A
- FBLG N/A
- 52 Week Low
- CMPX $0.77
- FBLG $1.08
- 52 Week High
- CMPX $2.34
- FBLG $46.00
- Technical
- Relative Strength Index (RSI)
- CMPX 62.58
- FBLG N/A
- Support Level
- CMPX $1.42
- FBLG N/A
- Resistance Level
- CMPX $1.86
- FBLG N/A
- Average True Range (ATR)
- CMPX 0.15
- FBLG 0.00
- MACD
- CMPX 0.01
- FBLG 0.00
- Stochastic Oscillator
- CMPX 62.09
- FBLG 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.